Literature DB >> 18194728

Cell damage and autoimmunity: a critical appraisal.

Ian R Mackay1, Natasha V Leskovsek, Noel R Rose.   

Abstract

In April 2007, an international Colloquium bridging scientific and clinical disciplines was held to discuss the role of cellular and tissue damage in the initiation, development and persistence of autoimmune disease. Five potential etiologic and pathophysiologic processes fundamental to autoimmune disease (i.e. inflammation, infection, apoptosis, environmental exposure and genetics) were the focus of the presentations and integrative discussions at the Colloquium. The information presented on these topics is condensed in this review. Inflammation has close clinico-pathologic associations with autoimmunity, but future analyses will require better definition and metrics of inflammation, particularly for the earliest cellular and molecular components dependent on recruitment of elements of innate immunity. Although infection may be associated with increased levels of autoantibodies, most infections and virtually all vaccinations in humans lack well-established links to autoimmune diseases. Further application of well-designed, long-term epidemiologic and population-based studies is urgently needed to relate antecedent exposures with later occurring stigmata of autoimmunity with a goal of discerning potentially susceptible individuals or subpopulations. Suspect infections requiring closer interrogation include EB virus (SLE and other diseases), HCV (autoimmune hepatitis), beta hemolytic streptococci (rheumatic carditis) and Helicobacter pylori (autoimmune gastritis) among others. And even if a micro-organism was to be incriminated, mechanisms of initiation/perpetuation of autoimmunity continue to challenge investigators. Plausible mechanisms include potentiation and diversion of innate immunity; exposure or spillage of intracellular autoantigens; or provision of autoantigenic mimics. Integrity of apoptosis as a critical safeguard against autoimmunity was discussed in the contexts of over-reactivity causing autoantigens to gain enhanced exposure to the immune system, or under-reactivity producing insufficient elimination of autoreactive clones of lymphocytes. Although environmental agents are widely believed to serve as necessary "triggers" of autoimmune disease in genetically predisposed individuals, only a few such agents (mainly drugs and some nutrients) have been clearly identified and their mechanism of action defined. Finally an essential genetic foundation underlies all these hazards for autoimmunity in the form of risk-associated polymorphisms in immunoregulatory genes. They may be predictive of future or impending disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194728      PMCID: PMC2231525          DOI: 10.1016/j.jaut.2007.11.009

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  86 in total

1.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

2.  A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease.

Authors:  Z L Awdeh; Edmond J Yunis; Mark J Audeh; Dolores Fici; Alberto Pugliese; Charles E Larsen; Chester A Alper
Journal:  J Autoimmun       Date:  2006-10-17       Impact factor: 7.094

3.  Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis.

Authors:  Roman Rieger; Patrick S C Leung; Melissa R Jeddeloh; Mark J Kurth; Michael H Nantz; Kit S Lam; Daniel Barsky; Aftab A Ansari; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  J Autoimmun       Date:  2006-07-28       Impact factor: 7.094

4.  Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling.

Authors:  Karen H O'Connor; J Paul Banga; Connie Darmanin; Ossama El-Kabbani; Ian R Mackay; Merrill J Rowley
Journal:  J Autoimmun       Date:  2006-03-24       Impact factor: 7.094

5.  2nd conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005.

Authors:  Andrea Doria; Piercarlo Sarzi-Puttini; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2005-08-10       Impact factor: 9.754

Review 6.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.

Authors:  Y H Lee; Y H Rho; S J Choi; J D Ji; G G Song; S K Nath; J B Harley
Journal:  Rheumatology (Oxford)       Date:  2006-06-07       Impact factor: 7.580

7.  IL-2 receptor alpha deficiency and features of primary biliary cirrhosis.

Authors:  Christopher A Aoki; Chaim M Roifman; Zhe-Xiong Lian; Christopher L Bowlus; Gary L Norman; Yehuda Shoenfeld; Ian R Mackay; M Eric Gershwin
Journal:  J Autoimmun       Date:  2006-08-10       Impact factor: 7.094

8.  How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.

Authors:  Isao Matsumoto; Mariana Maccioni; David M Lee; Madelon Maurice; Barry Simmons; Michael Brenner; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

9.  The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

Authors:  T Lasky; G J Terracciano; L Magder; C L Koski; M Ballesteros; D Nash; S Clark; P Haber; P D Stolley; L B Schonberger; R T Chen
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

10.  New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity.

Authors:  Stefania Recalcati; Pietro Invernizzi; Paolo Arosio; Gaetano Cairo
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

View more
  48 in total

1.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 2.  Infections and the antiphospholipid syndrome.

Authors:  Mario García-Carrasco; Claudio Galarza-Maldonado; Claudia Mendoza-Pinto; Ricardo O Escarcega; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 3.  Atherosclerosis and autoimmunity.

Authors:  Eiji Matsuura
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 4.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

Review 5.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice.

Authors:  Huiming Sheng; Saleema Hassanali; Courtney Nugent; Li Wen; Emma Hamilton-Williams; Peter Dias; Yang D Dai
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

Review 7.  Common innate pathways to autoimmune disease.

Authors:  David Langan; Noel R Rose; Kamal D Moudgil
Journal:  Clin Immunol       Date:  2020-02-10       Impact factor: 3.969

8.  Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage?

Authors:  Szilvia Szamosi; Zoltán Csiki; Edit Szomják; Erzsébet Szolnoki; Gabriella Szoke; Zoltán Szekanecz; Gyula Szegedi; Yehuda Shoenfeld; Gabriella Szucs
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 9.  The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology.

Authors:  Eric M Jacobson; Amanda Huber; Yaron Tomer
Journal:  J Autoimmun       Date:  2008-01-04       Impact factor: 7.094

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.